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Abstract 
 
Background: Most people with epilepsy lead a normal emotional and cognitive life, however neurobehavioral 
problems can be found in a large number of patients. This study evaluates the prevalence of depression and 
anxiety among patients with epilepsy and determines whether having other chronic somatic illnesses increases 
the prevalence. 
 
Methods: Adults with epilepsy were recruited in either the inpatient epilepsy monitoring unit or the Outpatient 
Epilepsy Clinic at Thomas Jefferson University in 2006. Patients anonymously filled out a questionnaire, included 
data about age, sex, education, having other chronic illnesses, and degree of seizure control. The Hospital Anxi-
ety and Depression scale was used to define the presence or absence of anxiety and depression.   
 
Results: Two hundreds patients participated, with a mean age of 40.3±16 years. Nineteen (9.5%) patients had 
depression and 49 (24.5%) had anxiety. Age, seizure control, and having other chronic illnesses did not have a 
significant relationship with either depression or anxiety. Gender was significantly related to anxiety, with females 
displaying greater frequency of anxiety than males. Depression was inversely related to education.  
 
Conclusions: It is probable that people with higher education use more effective ways to psychologically and 
physically adapt to their illness 
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Introduction 
 
Most people with epilepsy have a normal emotional 
and cognitive life, however neurobehavioral problems 
can be found in a large number of patients. Higher 
rates of psychopathology have been reported in peo-
ple with epilepsy compared with the general popula-
tion, other neurological control groups, and with peo-
ple with chronic non-neurological disorders.
1 Depres-
sion and anxiety are the most frequent types of psy-
chiatric disorders identified in patients with epilepsy.
2 
Some  demographic  and  clinical  variables  such  as 
gender  and  education  may  affect  the  prevalence  of 
depression or anxiety.
3,4   
Depression and anxiety are also frequently found 
coexisting with other long-standing chronic medical 
conditions.
5  Nearly,  half  of  asthma  patients,
6  and 
many persons with arthritis,
7 cancer,
8 diabetes melli-
tus,
9,10 and cardiovascular disorders
11 suffer from de-
pression  and/or  anxiety.  The  comorbidity  of  major 
depressive disorder or anxiety is associated with med-
ical, psychiatric, and social problems. On the other 
hand, effective recognition and treatment of depres-
sion and anxiety may be associated with functional 
improvement in patients with comorbid medical dis-
orders.
3  
It is well known that depression and anxiety are 
common  among  patients  with  epilepsy.  However, 
factors that might increase the prevalence of depres-
sion or anxiety in patients with epilepsy are not de-
termined well. The aim of this study was to evaluate 
the prevalence of depression and anxiety among pa-
tients with epilepsy referred to a tertiary center and to 
determine  whether  having  other  chronic  somatic  
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illnesses  increases  their  prevalence.  The  secondary 
objective was to determine whether certain clinical and 
demographic variables, including age, gender, educa-
tional  level  and  seizures  control  were  related  to  the 
prevalence of depression or anxiety in these patients. 
 
 
Materials and Methods 
 
In a cross-sectional questionnaire study, adults with a 
clinical diagnosis of epilepsy were recruited in either 
the inpatient  epilepsy-monitoring  unit  or the outpa-
tient epilepsy clinic at Thomas Jefferson University 
from  September  through  December  2006.  Patients 
aged 18 and above with a diagnosis of epilepsy for at 
least one year were eligible for this study. The diag-
nosis of epilepsy was made on clinical grounds by a 
board certified neurologist/epileptologist and all pa-
tients had to be taking anti-epileptic medications.     
The  questionnaires  were  filled  out  anonymously 
and included some details about gender, age, educa-
tional level (high school, some college, college grad-
uate or higher), having other illnesses (other illness 
defined as any chronic somatic illness that requires 
continuing treatment), and degree of seizure control 
(presence  or  absence  of  seizures  in  the  past  six 
months). Complete seizure control was defined as no 
seizure of any type in the last 6 months prior to inter-
view.  The  Hospital  Anxiety  and  Depression  scale 
(HAD scale) was used to evaluate the anxiety level 
and depression in epilepsy patients. HAD scale was 
designed to assess symptoms of anxiety and depres-
sion in patients with somatic diseases.
12 The severe 
psychopathological symptoms and somatic symptoms 
of anxiety and depression were not included in the 
questionnaire. The HAD scale consisted of 14 items, 
measuring  anxiety  and  depression  on  two  separate 
subscales, each consisting of 7 items. There were four 
response categories, from 0 to 3 to each item with a 
maximum  total  for  each  subscale  of  21.  The  low 
scores reflected absence of anxiety and/or depression, 
and > 10 score indicated a definite case on each sub-
scale.  In  a  number  of  studies,  the  HAD  scale  was 
shown to be reliable and valid in assessing anxiety 
and depression.
13-15 
Demographic variables and relevant clinical varia-
bles (i.e., age, gender, and educational level, seizure 
control,  having  depression  or  anxiety,  and  having 
chronic  illnesses other than  epilepsy)  were summa-
rized descriptively to characterize the study popula-
tion.  Statistical  analyses  were  performed  using  Chi 
Square, and logistic regression to determine potential-
ly  significant  associations,  and  a  p  value  less  than 
0.05 was considered significant. In the first analysis, 
depression was the dependent variable, and age, gen-
der,  education,  seizure  control,  and  having  other 
chronic illnesses were the independent variables. In the 
second analysis, anxiety was the dependent variable, 
and age, gender, education, seizure control, and having 
other chronic illnesses were the independent variables. 
This study was conducted with approval by the Thom-
as Jefferson University Institutional Review Board. 
 
 
Results 
 
Two  hundred  patients  filled  out  the  questionnaires. 
The questionnaires were filled out anonymously, and 
about 15% of subjects were drawn from the Epilepsy 
Monitoring Unit and 85% from the Outpatient Epi-
lepsy Clinic. Demographic and relevant clinical vari-
ables were summarized in Table 1. 
 
 
Table 1: Demographic and clinical variables of pa-
tients studied
a 
Age (years)  40.3±16 (mean±SD) 
Gender [Number (%)] 
Male  86 (43) 
Female  112 (56) 
Education [Number (%)] 
High school or less  71 (35.5) 
Some college  43 (21.5) 
College graduate  83 (41.5) 
Seizure control [Number (%)] 
Completely controlled  60 (30) 
Uncontrolled  133 (66.5) 
Depression based on HAD scale score [Number (%)] 
Patients with depres-
sion 
19 (9.5) 
Patients without de-
pression 
181 (90.5) 
Anxiety based on HAD scale score [Number (%)] 
Patients with anxiety  49 (24.5) 
Patients without anx-
iety 
151 (75.5) 
Chronic illnesses other than epilepsy [Number (%)] 
Patients with other 
illness 
58 (29) 
Patients without other 
illness 
141 (70.5) 
aSome data (less than 5.5%) were missing in each 
category; therefore the sum in each category may 
be less than 200. Asadi-Pooya et al. 
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With logistic regression analysis, a significant re-
lationship was observed between education and de-
pression; they had an inverse relationship (p=0.02). 
Less  educated  patients  were  more  often  depressed 
than well-educated patients. Twelve out of 71 patients 
(16%) with high school education had depression, but 
just three in 83 patients (3%) with college graduate or 
higher educational level had depression. Age, gender, 
seizure  control,  and  having  other  chronic  illnesses 
were not related to having depression. With logistic 
regression analysis, a significant model that incorpo-
rated  all  the  variables  was  not  observed  to  predict 
anxiety (p=0.15). Age, education, seizure control, and 
having other chronic illnesses were not significantly 
related  to  having  anxiety.  However,  subanalysis 
showed that anxiety was significantly related to gen-
der within the model (p=0.013). Their relation was 
also  significant  with  a  separate  analysis  using  Chi 
Square test (
2 = 6.2, p=0.01). Thirty-five out of 112 
women (31%) had anxiety, but only 14 in 86 (16%) 
men reported anxiety. Fifty-eight patients (29%) re-
ported having one or more chronic somatic disorders 
in addition to their epilepsy of which twelve patients 
had two or more other chronic disorders. Having mul-
tiple (two or more) chronic somatic disorders was not 
related  to  either  anxiety  or  depression.  The  most 
common chronic disorders reported were high blood 
pressure (11 patients), asthma (9 patients), hypothy-
roidism  (9  patients),  diabetes  (7  patients),  hyper-
lipidemia (5 patients), arthritis (5 patients), autoim-
mnune disorders including systemic lupus erythema-
tosus (3 patients), and cardiac disorders (3 patients).  
 
 
Discussion 
 
In our study, the prevalence of anxiety among epilep-
sy patients was 24.5% and the prevalence of depres-
sion was 9.5%. The prevalence of anxiety among epi-
lepsy patients is variable in different studies, from as 
low as 15% to as high as 25%.
5 The prevalence of 
depression among epilepsy patients is also variable in 
different studies,  from  as  low  as  9% to  as high  as 
55%.
16-19 These various prevalences are possibly due 
to the different methodology in different studies in-
cluding method of patient selection (e.g., hospital or 
community based) and the method of evaluation for 
depression and anxiety (different scales). The preva-
lence of depression and anxiety in patients with other 
chronic  illnesses  is  also  variable  probably  for  the 
same  reason,
5-11,20  however  it  is  higher  than  the  
general population. Depression and anxiety have im-
portant  implications  in  patients  with  other  chronic 
illnesses. They may affect the quality of life, func-
tioning, self-care behaviors, and consequently treat-
ment success in patients with chronic disorders.
5, 21 In 
addition, depressive and anxiety disorders assume an 
important role in the etiology, course, and outcomes 
associated  with  chronic  diseases.
22,23  There  is  quite 
convincing  evidence  regarding  relationship  between 
diseases  of  the  psyche  and  conditions  affecting  the 
cardiovascular system. This association is particularly 
strong in patients with depression and phobic anxiety. 
Depressive symptoms seem to be influential in pre-
dicting  ischemic  heart  diseases.  Phobic  anxiety  has 
also a clear association with increased risk of sudden 
cardiac death, which is probably related to increased 
susceptibility to arrhythmias. These associations with 
increased  myocardial  mortality  have  clinical  thera-
peutic implications.
23 In one study,
24 it was observed 
that  antidepressant  drug  adherence  was  associated 
with  increased  comorbid  disease  medication  adher-
ence and reduced total medical costs. 
In this study, depression was more frequent among 
epilepsy patients with less education. In a prospective 
study,
4 predictive factors influencing the 2-year out-
come of  major depressive episodes were evaluated. 
Among the tested variables, anxious personality traits 
and a lower level of education predicted a high level 
of depressive symptoms. Individuals with higher lev-
els of education may generally have greater cognitive 
resources, which in turn facilitate better coping strat-
egies and adjustment to life with epilepsy. It is proba-
ble that people with higher education use more effec-
tive ways to psychologically and physically adapt to 
their illness and engage in more active coping strate-
gies. Conversely, a low level of education may be a 
marker for a number of other underlying explanatory 
factors such as impaired cognition, that contribute to 
relatively poorer psychological adjustment.  
This study has several limitations. One limitation 
is the collection of data from a tertiary epilepsy cen-
ter. Therefore, these results may not be generalized. 
In addition, because the surveys were anonymously 
completed, certain information including seizure clas-
sification and seizure type, antiepileptic drugs or oth-
er drugs that might affect mood or anxiety are lack-
ing. Finally, the relation between anxiety and gender 
needs further exploration, since there were a larger 
number of females compared with males in our study 
and also the logistic regression model was not signifi-
cant.  Depression and anxiety in epilepsy 
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In this study, having one or more chronic illness in 
addition to epilepsy did not increase the prevalence of 
depression or anxiety. The prevalence of depression 
and anxiety in patients with epilepsy, with and with-
out other chronic somatic illnesses was not signifi-
cantly different. However, the prevalence of depres-
sion  and  anxiety  in  patients  with  non-neurological 
chronic illnesses is higher than the general popula-
tion.
25 The clinical implication of our study is that in 
epilepsy, anxiety and depression are more likely re-
lated to the endogenous factors such as neurochemi-
cal, electrophysiological and structural abnormalities 
in the CNS rather than the general disease burden. 
Further  community-based  studies  may  address 
these  issues.  Effective  recognition and treatment  of 
anxiety and depression in patients with epilepsy may 
be  associated  with  improved  quality  of  life,  better 
functioning, more beneficial self-care behaviors, and 
consequently treatment success in these patients.
21 In 
addition, attention to anxiety and depression may pos-
itively impact the economic burden of the comorbid 
disorders.
5 Therefore, recognition of risk factors that 
might increase the prevalence of anxiety or depres-
sion in patients with epilepsy is important. 
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